Medtronic: Strength In Cardiac Ablation Solutions, Upgrade To Buy
Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...
Becker's Hospital Review9h
Medtronic recalls embolization devices; 4 deaths reported
Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of ...
American Hospital Association11h
FDA issues recall on Medtronic embolization devices
The Food and Drug Administration has identified a Class I recall of Medtronic Neurovascular 027 Compatible Pipeline Vantage ...
“A Lifesaving Opportunity” – Jim Cramer on Medtronic plc (MDT)’s AI-Powered Future
We recently published a list of Was Jim Cramer Right About These 13 Stocks? In this article, we are going to take a look at ...
MedTech Dive16h
Medtronic recalls embolization devices tied to 17 injuries, 4 deaths
Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...
Modern Healthcare17h
FDA deems Medtronic’s Pipeline Vantage recall ‘most serious’
The recall, which affects two models of Pipeline Vantage embolization devices, is linked to 17 injuries and four deaths.
Medical Device Network on MSN18h
FDA tags Medtronic embolisation device recall as Class I
Medtronic initiated the recall of certain Pipeline Vantage embolisation devices in January 2025 following reports of four ...
NEJM Catalyst18h
A Novel 10-Year Value-Based Contract to Improve Type 1 Diabetes Care in the Netherlands
Four years into the mutually negotiated 10-year contract between Diabeter, a type 1 diabetes mellitus care-integrated ...
Medtronic PLC stock underperforms Tuesday when compared to competitors
The stock's fall snapped a three-day winning streak.
Medtronic slips after FDA notice on product recall (update)
Medtronic (MDT) stock turned lower as the FDA announced a most serious type of recall involving its Pipeline Vantage 027 ...
FDA classifies recall of Medtronic embolization devices as 'most serious'
The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...
FDA issues Medtronic embolization device recall and correction notice
In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...